Why is Vivimed Labs Ltd ?
1
With HIgh Debt (Debt-Equity Ratio at 9.51 times)- the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 12.57 times
- The company has been able to generate a Return on Equity (avg) of 1.75% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
- NO KEY NEGATIVE TRIGGERS
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 0.00%, its profits have fallen by -386%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
-53.40%
EBIT Growth (5y)
-421.22%
EBIT to Interest (avg)
-1.77
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
9.51
Sales to Capital Employed (avg)
0.80
Tax Ratio
0.64%
Dividend Payout Ratio
0
Pledged Shares
14.80%
Institutional Holding
1.76%
ROCE (avg)
-0.76%
ROE (avg)
1.75%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
32
Price to Book Value
1.28
EV to EBIT
-13.29
EV to EBITDA
-38.15
EV to Capital Employed
1.03
EV to Sales
3.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-71.39%
ROE (Latest)
-833.41%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend






